These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8773467)

  • 1. Brain sigma receptors labelled by [3H]nemonapride.
    Helmeste D; Tang SW; Fang H; Li M
    Eur J Pharmacol; 1996 Apr; 301(1-3):R1-3. PubMed ID: 8773467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brains.
    Tang SW; Helmeste DM; Fang H; Li M; Vu R; Bunney W; Potkin S; Jones EG
    Brain Res; 1997 Aug; 765(1):7-12. PubMed ID: 9310388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple [3H]-nemonapride binding sites in calf brain.
    Helmeste DM; Tang SW; Li M; Fang H
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):17-21. PubMed ID: 9228185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D4-like binding sites labeled by [3H]nemonapride include substantial serotonin 5-HT2A receptors in primate cerebral cortex.
    Noda-Saita K; Matsumoto M; Hidaka K; Hatanaka K; Ohmori J; Okada M; Yamaguchi T
    Biochem Biophys Res Commun; 1999 Feb; 255(2):367-70. PubMed ID: 10049714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
    J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo binding of [11C]nemonapride to sigma receptors in the cortex and cerebellum.
    Ishiwata K; Senda M
    Nucl Med Biol; 1999 Aug; 26(6):627-31. PubMed ID: 10587100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in sigma but no increase in striatal dopamine D4 sites in schizophrenic brains.
    Helmeste DM; Tang SW; Bunney WE; Potkin SG; Jones EG
    Eur J Pharmacol; 1996 Oct; 314(3):R3-5. PubMed ID: 8957266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D4-like receptor elevation in schizophrenia: cloned D2 and D4 receptors cannot be discriminated by raclopride competition against [3H]nemonapride.
    Seeman P; Van Tol HH
    J Neurochem; 1995 Mar; 64(3):1413-5. PubMed ID: 7861175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
    Tarazi FI; Florijn WJ; Creese I
    Neuroscience; 1997 Jun; 78(4):985-96. PubMed ID: 9174067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of [3H]nemonapride and [3H]spiperone binding on human dopamine D4 receptors.
    Hidaka K; Matsumoto M; Tada S; Tasaki Y; Yamaguchi T
    Neurosci Lett; 1995 Feb; 186(2-3):145-8. PubMed ID: 7777184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ; Tarazi FI; Creese I
    J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential in vivo inhibition of [3H]nemonapride binding by atypical antipsychotics in rat striatum, olfactory lobes, and frontal cortex.
    Assié MB; Consul-Denjean N; Koek W; Newman-Tancredi A
    Pharmacology; 2005 Oct; 75(2):63-8. PubMed ID: 16020947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding of both [3H]nemonapride and [3H]raclopride is increased in schizophrenia.
    Marzella PL; Hill C; Keks N; Singh B; Copolov D
    Biol Psychiatry; 1997 Oct; 42(8):648-54. PubMed ID: 9325557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D2-type dopamine receptors in postmortem human brain sections from normal and schizophrenic subjects.
    Lahti RA; Roberts RC; Conley RR; Cochrane EV; Mutin A; Tamminga CA
    Neuroreport; 1996 Aug; 7(12):1945-8. PubMed ID: 8905699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression.
    Sumiyoshi T; Stockmeier CA; Overholser JC; Thompson PA; Meltzer HY
    Brain Res; 1995 May; 681(1-2):109-16. PubMed ID: 7552267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]YM-09151-2 (nemonapride), a potent radioligand for both sigma 1 and sigma 2 receptor subtypes.
    Ujike H; Akiyama K; Kuroda S
    Neuroreport; 1996 Apr; 7(5):1057-61. PubMed ID: 8804051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand.
    Seeman P; Van Tol HH
    Eur J Pharmacol; 1995 Oct; 291(2):59-66. PubMed ID: 8566176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sigma1 and dopamine D2 receptor occupancy in the mouse brain after a single administration of haloperidol and two dopamine D2-like receptor ligands.
    Ishiwata K; Kawamura K; Kobayashi T; Matsuno K
    Nucl Med Biol; 2003 May; 30(4):429-34. PubMed ID: 12767400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
    Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain.
    Andersen PH
    Eur J Pharmacol; 1988 Jan; 146(1):113-20. PubMed ID: 2895008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.